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Introduction: Diabetes mellitus is a metabolic disease that has affected approximately 
10% of population worldwide. Cydonia oblonga Mill. (C. oblonga), commonly called 
quince, contains diverse phytochemical constituents with a broad range of 
pharmacological activities. The current study is aimed to investigate the 
antihyperglycemic effect of aqueous extract of Cydonia oblonga Mill. fruit (ACO) in 
streptozotocin-induced diabetic rats and to identify the active fraction.  
Methods and Results: Diabetes was induced in rats by a single intraperitoneal (i.p.) 
injection of 60 mg/kg streptozotocin. The antihyperglycemic activity of different 
concentrations of ACO (80, 160 and 240 mg/kg body weight daily for a period of 28 
days) was evaluated in the diabetic rats by measuring their fasting blood glucose 
(FBG). Furthermore, the antihyperglycemic effects of two major fractions of ACO 
were evaluated for the identification of active fraction. Finally, the chemical 
composition of the active fraction, methanolic fraction (MF), was examined by gas 
chromatography-mass spectrometry (GC-MS) assay. The oral administration of ACO 
on diabetic rats resulted in a significant collapse in FBG in a dose-dependent manner. 
In addition, the MF was the active fraction and exhibited antihyperglycemic activity in 
diabetic rats during the experiment. The main component of MF was identified as 5-
hydroxymethylfurfural or 5-HMF (a well-known natural compound) that may be 
responsible, at least partly, for the antidiabetic and antihyperglycemic effects of quince.  
Conclusion: Our results have demonstrated for the first time that quince possesses 
antihyperglycemic effect in diabetic rats and the MF of the aqueous extract is active 
fraction. 
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Diabetes mellitus is one of the most common chronic 
diseases, which is rapidly increasing in nearly all 
countries. The increasing prevalence of diabetes is one 
the most serious public health problems and it has been 
estimated that 552 million people will have diabetes by 
2030 worldwide [1]. The metabolic disease characterized 
by chronic hyperglycemia, which in turn results in 
diabetes complications such as cardiovascular diseases, 
neuropathy, nephropathy, and retinopathy [2, 3]. There is 
a growing trend of using herbal preparations in the 
glycemic control of diabetic patients and in the 
prevention and management of this progressive disease 
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[4]. This is because of their effectiveness, minimal 
undesirable side effects and comparatively low costs. In 
this regard, World Health Organization (WHO) 
commends the use of natural products for diabetic 
management [5]. 
Quince (Cydonia oblonga Mill.) belongs to the Rosacea 
family and is one of the medicinal plants that have been 
used in Iranian and Turkish traditional medicines for the 
management of diabetes [6-8]. Quince is a native plant in 
Iran and Turkey, and is popular for its nutritional and 
medicinal uses. Its fruit has a variety of valuable 
phytochemicals and has been used as a dietary source. 
The fruit of quince exhibited a broad spectrum of 
pharmacological activities such as antioxidant effect due 
to diverse phenolic compounds and flavonoids [9, 10]. It 
has been also reported that the fruit possesses anti-bacterial, 
anti-fungal, anti-hemolytic, anti-allergic, anti-ulcerative, 
anti-inflammatory, hepatoprotective, cardioprotective, 
and geno-protective effects [6, 11-17]. Recently, two 
research groups described antiproliferative activity of 
quince fruit against human kidney and colon cancer cells 
and suggested that a quince-rich regimen may be a 
promising agent for cancer prevention and treatment [18, 
19]. In this regard, we have previously demonstrated the 
preventive effect of quince fruit against hepatocellular 
carcinoma in rats [20]. 
We have previously shown that the aqueous extract of 
quince fruit prevented diabetes-related complications in 
streptozotocin-induced diabetic rats [8]. Our results 
revealed that quince fruit possesses hypolipidemic, 
hepatoprotective, and renoprotective effects in diabetic 
rats. Since hyperglycemia triggers a cascade of events 
that eventually leads to the diabetes complications, it can 
be concluded that the ameliorating effects of quince in 
these abnormalities may be originated from its 
antihyperglycemic activity [21]. Hence, the present study 
was designed to evaluate the potential antihyperglycemic 
activity of aqueous extract of Cydonia oblonga Mill. 
fruit (ACO) in streptozotocin-induced diabetic rats. We 
have also evaluated the antihyperglycemic effects of two 
major fractions of ACO to identify the active fraction 
and to examine the chemical composition of the active 
fraction by gas chromatography-mass spectrometry (GC-
MS) assay. 
2. Materials & Methods 
 
2.1. Chemicals 
Streptozotocin, gallic acid, quercetin, methanol and 
chloroform were purchased from Sigma-Aldrich Co. 
(Taufkrichen, Germany). 
2.2. Preparation of ACO 
Cydonia oblonga Mill. fruits were collected in October 
2015 from Shahriar, Alborz province, Iran and were 
authenticated by Mr. Mohammad Kamalinejad, a 
qualified botanist at, Shahid Beheshti University of 
Medical Sciences (8054, voucher specimen in Shahid 
Beheshti University of Medical Sciences Herbarium, 
Tehran, Iran). The fresh fruits were cleaned with their 
peels and the extraction was carried out by the 
maceration of 100 g fruit with 900 mL distilled water for 
30 min. The resulting extract was evaporated by placing 
in water bath 90°C. Finally, the extract was filtered and 
was kept at –20°C until use. The extract was dissolved in 
distilled water to receive desired concentrations just 
before use. The moisture level of the extract was 
determined by weight loss after placing 2 g of the final 
extract in an oven at 60–65°C for 72 h. The final extract 
contained 24% water [22]. 
2.3. Standardization of Extract 
Total polyphenol content was determined by 
spectrophotometry, using gallic acid as the standard 
based on the Folin–Ciocalteu method [23]. Total 
phenolic content was 49.13 ± 1.23 mg gallic acid 
equivalents (GAE) per gram of ACO (mg of GAE/g of 
plant extract). Total flavonoid content was measured 
with the aluminum chloride colorimetric assay [24]. 
Quercetin was used as the standard and flavonoid 
contents were expressed as mg of quercetin equivalent 
per gram of ACO. Flavonoid contents were 15.34 ± 0.93 
mg quercetin equivalents (QE) per gram of ACO (mg of 
QE /g of plant extract). 
2.4. Preparation of ACO fractions 
To prepare the methanolic fraction (MF), the fruit extract 
(5 g) was re-extracted with methanol (35 mL) under 
shaking for 4 h at an ambient temperature in a conical 
flask. The mixture was filtered and the filtrate was 
concentrated under a reduced pressure to get prepared 
for the experiment. Afterward, the semi-solid residue of 
the first fractionation (1.02 g) was further extracted with 
moderately polar solvent, chloroform [25]. 
2.5. Animals 
Male Sprague-Dawley rats weighing 200 to 250 g were 
housed in ventilated plastic cages over PWI 8-16 
hardwood bedding. There were 12 air changes per h, 12 
h light photoperiods, an environmental temperature of 
21–23°C, and a relative humidity of 50–60%. The 
animals were fed a standard normal chow diet and given 
tap water ad libitum. In the present study, the principles 
of laboratory animal care (NIH publication No. 85-23, 
revised 1985) were followed.  
2.6. Induction of diabetes in rats 
Experimental diabetes was induced in rats subsequent an 
overnight fast, by a single intraperitoneal (i.p.) injection 
of 60 mg/kg streptozotocin freshly prepared in citrate 
buffer (0.1M, pH 4.5) [26]. Non diabetic control animals 
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were injected with vehicle only. Diabetes was confirmed 4 
days after injection by measuring the tail vein blood 
glucose level. Only the animals with fasting blood glucose 
(FBG) levels ≥ 250 mg/dl were selected for the study. 
2.7. Experimental protocol and study design 
Initially, the three doses of 80, 160 and 240 mg/kg body 
weight daily were chosen based on our previous study [8]. 
Normal and diabetic rats were divided into six groups of 
six rats (n = 6). Group-1 non diabetic rats served as 
normal control group; Group-2 served as untreated 
diabetic control; Group-3 diabetic rats were treated with 
glibenclamide as a positive control at 10 mg/kg body 
weight. Groups- 4, 5, 6 diabetic rats were treated with 
ACO at 80, 160, and 240 mg/kg body weight, 
respectively. The different concentrations of the extract 
and glibenclamide were administered orally once daily 
using an intragastric tube for 4 weeks. The 
hypoglycemic effects of two major fractions of ACO 
were evaluated in diabetic rats by the measurement of 
FBS at time 0 and intervals of 1, 3, 5, and 7 h after single 
oral administration of the fractions (240 mg/kg body 
weight). 
2.8. Determination of blood glucose level 
Blood samples were collected from the tail vein of the 
overnight (12–15 h) fasting rat for the measurement of 
blood glucose level using a standardized glucometer 
(ARKAY, INC., Japan) [8]. 
2.9. GC-MS analysis of bioactive compounds 
The MF of the extract was subjected to GC-MS for the 
identification of bioactive volatile compounds. The 
analysis was carried out on an Agilent model, 6890 GC 
interfaced to a 5975C mass detector employing the 
following conditions: 
HP-5MS capillary column (30m × 0.25mm × 0.25 µm 
film thickness; Agilent, USA) was used. For the GC-MS 
detection, an electron ionization system with ionization 
energy of 70 eV was adopted. Helium gas (99.999%) 
was the carrier gas at a flow rate of 1 mL/min. The oven 
temperature was operated as follows: 50°C for 2 min, 
then raising at the rate of 5°C/min up to 280°C 
maintained for 10 min. Injector temperature and 
injection volume were 250°C and 1 µL, respectively. 
The relative percentage amount of each component was 
calculated by comparing its average peak area to the 
peak area of the most abundant component. 
Identification of compounds was based on comparisons 
of the relative retention indices and mass spectra with 
those of the Wiley and NIST library data standards of the 
GC-MS system. Retention indices were determined by 
analyzing a solution covering the homologous series of 
normal alkanes (C7–C22) and then calculated as 
described by van Den Dool and Kratz [27]. 
2.10. Statistical analysis 
The homogeneity of variances was tested using Levene’s 
test. The results were analyzed using one-way analysis 
of variance (ANOVA) followed by Tukey’s HSD as the 
post hoc test. FBG data in days 0 and 28 in each group 
were statistically preceded by means of Student's t-test. 
The data were presented as the mean ± SD (n=6). The 
minimum level of significance chosen was P < 0.05. 
3. Results 
 
3.1. Effects of ACO on FBG levels 
Our results showed that the oral administration of 
different concentrations of ACO on diabetic rats caused 
a significant decrease in FBG in a dose-dependent 
manner and the concentration of 240 mg/kg body 
weight/day was more effective than the other two 
concentrations (P < 0.001). However, the different 
concentrations of ACO were not as effective as 
glibenclamide, a standard antihyperglycemic drug (P < 
0.001) (Table 1 and Fig. 1). 
 
Table 1. Hypoglycemic effects of the different concentrations of ACO in streptozotocin-induced diabetic rats 
 Fasting Blood Glucose (mg/dl) 
 Day 0 Day 14 Day 28 
Normal rats 120±10 102±21 115±18 
Diabetic rats 373±21*** 377±31*** 376±18*** 
+ Glibenclamide 380±20 
NS 258±31### 174±16### 
+ ACO (80 mg/kg) 382±36
 NS 369±29 NS, ФФФ 343±18 NS, ФФФ 
+ ACO (160 mg/kg) 385±37
 NS 338±13 NS, ФФФ 306±28###, ФФФ 
+ ACO (240 mg/kg) 382±19
 NS 330±33 NS, ФФФ 236±23###, ФФФ 
Data are presented as mean±SD. 
  *** P < 0.001 compared to normal group in corresponding time 
  ###P <0.001 compared to diabetic group in corresponding time  
ФФФ P <0.001 compared to glibenclamide group in corresponding time 
NS: Not Significant 
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Figure 1. Hypoglycemic effects of the different concentrations of 
ACO in diabetic rats at the start and end of the experiment. Data are 
presented as mean±SD. *** P < 0.001 compared to day 0 in 
corresponding group; ФФФ P <0.001 compared to the other 
concentration at the same time; NS: Not Significant. 
 
3.2. Effects of ACO fractions on FBG levels 
In the current study, the effects of ACO fractions on the 
glucose levels of diabetic rats were evaluated for a 
 
period of 7 h. The fractions were only used as an oral 
single-dose (240 mg/kg) and FBG was excellently 
decreased in MF-treated rats; whereas chloroform 
fraction (CF) didn’t indicate any significant effect on 
the glucose levels (Fig. 2). 
 
 
Figure 2. Hypoglycemic effects of two major fractions of ACO in 
diabetic rats. Data are presented as mean±SD. MF: methanolic 
fraction-treated diabetic rats. CF: chloroformic fraction-treated 
diabetic rats. ### P <0.001 compared to diabetic group in 
corresponding time; *** P < 0.001 compared to CF-treated rats in 
corresponding time. 
 
















1 6.504 Furfural C5H4O2 96 13.48 4.6 858 




C6H8O4 144 1.92 0.65 991 
4 13.434 Furaneol C6H8O3 128 4.91 1.68 1090 
5 15.831 Dihydroxymaltol C6H8O4 144 20.06 6.9 1100 
6 17.229 Desulphosinigrin C10H17NO6S 279 4.41 1.51 1214 
7 18.777 5-Hydroxymethylfurfural C6H6O3 126 100.00 34.2 1271 
8 20.207 furoic acid-2-Methyl-3 C6H6O3 126 24.76 8.5 1341 






Figure 3.  GC-MS chromatogram of the methanolic fraction of Cydonia oblonga Mill. fruit extract 
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Figure 4. Mass spectrum of 5-HMF 
 
 
Figure 5. Mass spectrum of DMHF 
 
3.3. GC-Mass analysis of the methanolic fraction of 
ACO 
Based on the GC-MS analysis, the MF of the fruit 
extract contained more than twenty compounds. The 
chemical components of those were identified, the 
percentage of peak area of each constituent and their 
retention times and indices were summarized in the 
Table 2. The total ion chromatogram of the MF and the 
mass spectra of two main components were depicted in 
Figs. 3-5, respectively. The main components of the MF 
were identified as furfural (4.6%), dihydroxymaltol 
(6.9%), 5-hydroxymethylfurfural or 5-HMF (34.2%), 
and 3-methyl-2-furoic acid (8.5%). Among them, the 
most abundant compound found was 5-HMF. 
 
4. Discussion and Conclusion 
This is the first report showing antihyperglycemic 
activity of Cydonia oblonga Mill. fruit in 
streptozotocin-induced diabetic rats. Hyperglycemia is 
the defining feature of diabetes mellitus that can result 
in microvascular and macrovasculr diabetic 
complications which might be disabling or even life-
threatening [2]. Therefore, many attempts have been 
made to control the glucose levels of diabetic patients 
and glycemic control is the basic principal of diabetes 
management. In addition to different classes of 
antihyperglycemic drugs, herbal medicines have been 
utilized to manage diabetes mellitus and its co-morbid 
conditions throughout human history. 
Aslan et al. (2010) revealed that the methanolic extract 
of quince leaves at the dose of 500 mg/kg body weight 
twice daily for 5 consecutive days had antihyperglycemic 
property in streptozotocin-induced diabetic rats [7]. The 
results of our previous study indicated that ACO (80, 
160 and 240 mg/kg body weight daily for 6 weeks) 
attenuated dyslipidemia in diabetic rats and efficiently 
reduced serum triglyceride, total cholesterol, and LDL-
C that was accompanied with the elevated levels of 
HDL-C. The fruit extract also significantly reduced the 
biochemical markers of liver and renal damage in 
diabetic rats, including ALT, AST, ALP, urea, and 
creatinine [8]. Since the elevated levels of glucose in 
diabetes lead to the development and progression of 
diabetes complications [28], it can be suggested that the 
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hypolipidemic, hepatoprotective, and renoprotective 
effects of ACO in diabetic rats may be arisen from the 
antihyperglycemic activity of the fruit. 
It is evident from our results that ACO exhibited 
significant antihyperglycemic effect in a dose-
dependent manner and the highest dose of the ACO 
(240 mg/kg) caused a significant decrease of about 
38.2% in FBG after 4 weeks of treatment. In addition, 
the doses of 80 and 160 mg/kg exhibited 10.2% and 
20.5% decline in FBG, respectively. On the other hand, 
glibenclamide, a standard oral hypoglycemic agent, 
showed a better antihyperglycemic effect compared to 
the different doses of ACO and presented 54.2% 
reduction in FBG at the end of the experiment (Fig. 1). 
In the second part of the study, the antihyperglycemic 
effects of ACO derived fractions were evaluated to 
identify the active fraction in diabetic rats. In order to 
achieve the fractions, two different organic solvents, 
methanol and chloroform, were used due to their 
different polar natures. The MF showed a potent 
antihyperglycemic effect compared to chloroform 
fraction during the experiment. So, it was concluded 
that MF contains active constituents responsible for the 
antihyperglycemic effect of ACO. 
Previous studies have identified numerous volatile 
compounds in quince fruit that impart characteristic 
odor to the fruit [29-31]. So in the current study, 
GC/Mass analysis was used for the detection of the 
active constituents of MF. The results of our 
investigation revealed that this fraction contains 5-
hydroxymethylfurfural known as 5-HMF. 5-
Hydroxymethyl-2-furancarboxaldehyde (5-HMF) is a 
naturally occurring compound of plant origin found in 
different natural resources. The present study is the first 
report showing that Cydonia oblonga Mill. fruit 
contains 5-HMF at a high concentration. The compound 
exhibited various biological properties, including 
antioxidant, cytoprotective, anti-atherosclerosis, and 
antitumor activity [32-35]. Furthermore, this active 
compound protected human vein epidermal cell against 
glucose and hydrogen peroxide-induced liver damage in 
mice [36]. It has been also reported that 5-HMF 
inhibited high glucose-induced oxidative stress in 
human umbilical vein endothelial cells and it was 
concluded that 5-HMF can be a promising agent for the 
prevention of diabetes and its associated vascular 
diseases [37]. Considering 5-HMF has inhibited the 
toxic consequences of glucose and our results showed 
the antihyperglycemic activity of ACO; it can be 
suggested that 5-HMF may be one of the active 
components responsible for the glucose-lowering effect 
of quince fruit. Data in our study will definitely 
encourage future studies to increase our understanding 
on the antidiabetic and antihyperglycemic potential of 
5-HMF. 
2, 5-dimethyl-4-hydroxy -3(2H)-furanone (DMHF), also 
known as furaneol is another compound detected in the 
MF of the extract. DMHF is an aroma compound found 
in many fruits and processed foodstuffs, including 
pineapples, mangos, grapes, raspberries, and 
strawberries and is widely used as a food flavoring [38]. 
DMHF exhibited antioxidant, anti-cataract, anti-
carcinogenic, antifungal, and antimicrobial effects in 
different in vivo and in vitro models [38]. As shown in 
Table 2, six additional natural compounds were 
identified in quince fruit. However, GC/Mass analysis 
only detects volatile components of the fraction and 
other groups of compounds were not identified. 
Therefore, further complementary studies are required 
to establish what kinds of molecules are responsible for 
the antidiabetic and antihyperglycemic effects of quince 
fruit and to fully explain the mechanisms underlying the 
effect. 
The different kinds of phenolic acids and flavonoids are 
present in quince fruit, including caffeoylquinic acids, 
kaempferol 3- glucoside, rutin, kaempferol-3-rutinoside, 
and quercetin 3-galactoside [9]. It has also been 
reported that this fruit contains 21 amino acids, vitamin 
C, pectin, tannins, and minerals such as calcium, 
sodium, potassium, and phosphorus [6, 39]. 
Polyphenolic compounds are natural phytochemicals 
that have been used to treat and prevent diabetes and 
affect various aspects of this chronic disease [40]. 
Polyphenols indicated remarkable antihyperglycemic 
effects in in vitro and in vivo models through different 
mechanisms. These natural compounds play beneficial 
roles in carbohydrate metabolism and glucose 
homeostasis by decreasing intestinal absorption of 
dietary carbohydrate and modulation of the enzymes 
involved in glucose metabolism [41]. In addition, they 
also improve β-cell function and stimulate insulin 
secretion [40, 42]. It has been also reported that 
phenolic acids, flavonoids, and tannins inhibited α-
glucosidase and α-amylase, which are responsible for 
the digestion of dietary carbohydrates to glucose [40-
43]. In this study, the extract was prepared from whole 
fruit and about 5% of the total weight related to 
polyphenols. Therefore, it can be concluded that the 
antihyperglycemic activity of quince fruit may be, at 
least partly, mediated through the hypoglycemic effects 
of polyphenols. Additionally, several studies reported 
the preventive effects of polyphenols against 
complications induced by diabetes [44, 45]. So, it can be 
said that the protective effects of quince fruit in our 
earlier study may be mediated by 5-HMF and/or 
polyphenols that present in the fruit [8]. 
To conclude, these findings clearly demonstrated that 
the fruit of quince has antihyperglycemic activity in 
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diabetic rats and the MF of the aqueous extract is the 
active fraction. Therefore, this valuable fruit can be 
considered as a suitable natural product for the 
management of diabetic patients and their glycemic 
control. This activity may be mediated through 5-HMF 
and/or polyphenols. Further studies to find out the 
active constituents and synergy among different 
compounds present in quince for controlling 
hyperglycemia would be complementary to this study. 
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